Annual Operating Profit
-$121.69 M
+$15.52 M+11.31%
September 30, 2024
Summary
- As of February 25, 2025, ENTA annual operating income is -$121.69 million, with the most recent change of +$15.52 million (+11.31%) on September 30, 2024.
- During the last 3 years, ENTA annual operating profit has fallen by -$12.12 million (-11.06%).
- ENTA annual operating profit is now -198.02% below its all-time high of $124.15 million, reached on September 30, 2015.
Performance
ENTA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$23.54 M
+$6.31 M+21.14%
December 31, 2024
Summary
- As of February 25, 2025, ENTA quarterly operating income is -$23.54 million, with the most recent change of +$6.31 million (+21.14%) on December 31, 2024.
- Over the past year, ENTA quarterly operating profit has stayed the same.
- ENTA quarterly operating profit is now -133.53% below its all-time high of $70.21 million, reached on December 31, 2014.
Performance
ENTA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$110.35 M
+$11.34 M+9.32%
December 31, 2024
Summary
- As of February 25, 2025, ENTA TTM operating income is -$110.35 million, with the most recent change of +$11.34 million (+9.32%) on December 31, 2024.
- Over the past year, ENTA TTM operating profit has stayed the same.
- ENTA TTM operating profit is now -174.39% below its all-time high of $148.34 million, reached on March 31, 2015.
Performance
ENTA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ENTA Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.3% | 0.0% | 0.0% |
| 3 y3 years | -11.1% | +27.6% | +15.5% |
| 5 y5 years | -431.2% | +30.2% | -0.7% |
ENTA Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.1% | +11.3% | at high | +40.3% | at high | +22.3% |
| 5 y | 5-year | -431.2% | +11.3% | -282.9% | +40.3% | -607.3% | +22.3% |
| alltime | all time | -198.0% | +11.3% | -133.5% | +40.3% | -174.4% | +22.3% |
Enanta Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$23.54 M(-21.1%) | -$110.35 M(-9.3%) |
| Sep 2024 | -$121.69 M(-11.3%) | -$29.85 M(+23.4%) | -$121.69 M(-1.0%) |
| Jun 2024 | - | -$24.18 M(-26.2%) | -$122.87 M(-9.3%) |
| Mar 2024 | - | -$32.77 M(-6.1%) | -$135.40 M(-4.7%) |
| Dec 2023 | - | -$34.89 M(+12.4%) | -$142.08 M(+3.6%) |
| Sep 2023 | -$137.21 M(+10.8%) | -$31.03 M(-15.5%) | -$137.21 M(+3.0%) |
| Jun 2023 | - | -$36.71 M(-6.9%) | -$133.22 M(+3.2%) |
| Mar 2023 | - | -$39.45 M(+31.4%) | -$129.05 M(+4.5%) |
| Dec 2022 | - | -$30.01 M(+11.0%) | -$123.45 M(-0.3%) |
| Sep 2022 | -$123.84 M(+13.0%) | -$27.05 M(-16.9%) | -$123.84 M(-5.1%) |
| Jun 2022 | - | -$32.54 M(-3.9%) | -$130.52 M(-1.0%) |
| Mar 2022 | - | -$33.85 M(+11.3%) | -$131.83 M(+3.2%) |
| Dec 2021 | - | -$30.41 M(-9.8%) | -$127.68 M(+16.5%) |
| Sep 2021 | -$109.57 M(+163.1%) | -$33.73 M(-0.4%) | -$109.57 M(+14.6%) |
| Jun 2021 | - | -$33.85 M(+14.0%) | -$95.63 M(+13.0%) |
| Mar 2021 | - | -$29.70 M(+141.5%) | -$84.63 M(+26.7%) |
| Dec 2020 | - | -$12.30 M(-37.8%) | -$66.81 M(+60.4%) |
| Sep 2020 | -$41.64 M(-213.3%) | -$19.78 M(-13.4%) | -$41.64 M(+169.9%) |
| Jun 2020 | - | -$22.85 M(+92.4%) | -$15.43 M(-237.9%) |
| Mar 2020 | - | -$11.88 M(-192.3%) | $11.18 M(-48.6%) |
| Dec 2019 | - | $12.87 M(+100.1%) | $21.75 M(-40.8%) |
| Sep 2019 | $36.74 M(-58.4%) | $6.43 M(+71.3%) | $36.74 M(-43.3%) |
| Jun 2019 | - | $3.75 M(-388.0%) | $64.76 M(-22.6%) |
| Mar 2019 | - | -$1.30 M(-104.7%) | $83.64 M(-17.8%) |
| Dec 2018 | - | $27.86 M(-19.1%) | $101.81 M(+15.3%) |
| Sep 2018 | $88.33 M | $34.45 M(+52.2%) | $88.33 M(-18.3%) |
| Jun 2018 | - | $22.64 M(+34.3%) | $108.17 M(+49.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $16.86 M(+17.3%) | $72.40 M(+57.3%) |
| Dec 2017 | - | $14.38 M(-73.5%) | $46.04 M(+87.0%) |
| Sep 2017 | $24.61 M(-20.2%) | $54.30 M(-513.6%) | $24.61 M(-175.1%) |
| Jun 2017 | - | -$13.13 M(+38.1%) | -$32.78 M(+58.1%) |
| Mar 2017 | - | -$9.51 M(+34.9%) | -$20.74 M(+75.8%) |
| Dec 2016 | - | -$7.05 M(+127.4%) | -$11.80 M(-138.3%) |
| Sep 2016 | $30.84 M(-75.2%) | -$3.10 M(+184.6%) | $30.84 M(-18.0%) |
| Jun 2016 | - | -$1.09 M(+92.7%) | $37.61 M(-6.9%) |
| Mar 2016 | - | -$565.00 K(-101.6%) | $40.41 M(-54.9%) |
| Dec 2015 | - | $35.59 M(+868.8%) | $89.53 M(-27.9%) |
| Sep 2015 | $124.15 M(+553.9%) | $3.67 M(+115.7%) | $124.15 M(+7.8%) |
| Jun 2015 | - | $1.70 M(-96.5%) | $115.15 M(-22.4%) |
| Mar 2015 | - | $48.56 M(-30.8%) | $148.34 M(+56.7%) |
| Dec 2014 | - | $70.21 M(-1418.3%) | $94.65 M(+398.6%) |
| Sep 2014 | $18.98 M(+110.3%) | -$5.33 M(-115.3%) | $18.98 M(-3.2%) |
| Jun 2014 | - | $34.90 M(-780.6%) | $19.61 M(-200.8%) |
| Mar 2014 | - | -$5.13 M(-6.0%) | -$19.46 M(+6.1%) |
| Dec 2013 | - | -$5.46 M(+16.1%) | -$18.34 M(-303.1%) |
| Sep 2013 | $9.03 M(-57.6%) | -$4.70 M(+12.5%) | $9.03 M(-6.3%) |
| Jun 2013 | - | -$4.18 M(+4.4%) | $9.63 M(-6.3%) |
| Mar 2013 | - | -$4.00 M(-118.3%) | $10.28 M(-77.8%) |
| Dec 2012 | - | $21.91 M(-634.9%) | $46.38 M(+117.9%) |
| Sep 2012 | $21.29 M(-15.9%) | -$4.10 M(+16.1%) | $21.29 M(+0.2%) |
| Jun 2012 | - | -$3.53 M(-111.0%) | $21.25 M(-14.2%) |
| Mar 2012 | - | $32.09 M(-1108.6%) | $24.78 M(-438.9%) |
| Dec 2011 | - | -$3.18 M(-23.0%) | -$7.31 M(+77.0%) |
| Sep 2011 | $25.30 M(+264.4%) | -$4.13 M | -$4.13 M |
| Sep 2010 | $6.94 M | - | - |
FAQ
- What is Enanta Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual operating profit year-on-year change?
- What is Enanta Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly operating profit year-on-year change?
- What is Enanta Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals TTM operating profit year-on-year change?
What is Enanta Pharmaceuticals annual operating income?
The current annual operating profit of ENTA is -$121.69 M
What is the all time high annual operating profit for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual operating income is $124.15 M
What is Enanta Pharmaceuticals annual operating profit year-on-year change?
Over the past year, ENTA annual operating income has changed by +$15.52 M (+11.31%)
What is Enanta Pharmaceuticals quarterly operating income?
The current quarterly operating profit of ENTA is -$23.54 M
What is the all time high quarterly operating profit for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly operating income is $70.21 M
What is Enanta Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, ENTA quarterly operating income has changed by $0.00 (0.00%)
What is Enanta Pharmaceuticals TTM operating income?
The current TTM operating profit of ENTA is -$110.35 M
What is the all time high TTM operating profit for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high TTM operating income is $148.34 M
What is Enanta Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, ENTA TTM operating income has changed by $0.00 (0.00%)